Immune Responses in Patients Treated With Raltegravir (RAG-1/2)

This study has been withdrawn prior to enrollment.
(Unexpected and severe difficulties in recruitment.)
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Chris Tsoukas, McGill University Health Center
ClinicalTrials.gov Identifier:
NCT00785967
First received: November 4, 2008
Last updated: April 13, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: August 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)